Literature DB >> 10474639

Serological assays on eight cases of human dirofilariasis identified by morphology and DNA diagnostics.

G Cancrini1, G Prieto, G Favia, S Giannetto, R Tringali, M Pietrobelli, F Simón.   

Abstract

Specimens of Dirofilaria sp. removed from eight Italian patients were identified as D. repens by morphology and confirmed as such by a PCR-based method of DNA analysis. Blood samples were also drawn from the patients so that two serological tests (ELISA and western blot), one based on the recognition of molecular markers recently identified in the somatic antigenic complex of D. repens, could be evaluated. The antigenic complex used in the ELISA only gave a weak sensitivity. However, the western-blot assays, based on the polypeptide molecular markers, were found to have greater sensitivity and should be useful in detecting human cases of dirofilariasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10474639     DOI: 10.1080/00034989958627

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  4 in total

1.  An interesting case of a subcutaneous nodule.

Authors:  Basavaprabhu Achappa; Deepak Madi; Soundarya Mahalingam
Journal:  J Clin Diagn Res       Date:  2013-02-01

Review 2.  Human and animal dirofilariasis: the emergence of a zoonotic mosaic.

Authors:  Fernando Simón; Mar Siles-Lucas; Rodrigo Morchón; Javier González-Miguel; Isabel Mellado; Elena Carretón; Jose Alberto Montoya-Alonso
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Orbital dirofilariasis in Iran: a case report.

Authors:  Sepideh Tavakolizadeh; Iraj Mobedi
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

4.  Seroreactivity to Dirofilaria antigens in people from different areas of Serbia.

Authors:  Suzana A Tasić-Otašević; Simona V Gabrielli; Aleksandar V Tasić; Nataša L Miladinovićtasić; Jovana T Kostić; Aleksandra M Ignjatović; Lidija D Popović Dragonjić; Zoran G Milošević; Valentina S Arsić-Arsenijević; Gabriella A Cancrini
Journal:  BMC Infect Dis       Date:  2014-02-08       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.